SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice

Version 4 2020-09-15, 15:41

Version 3 2020-04-09, 13:59

Version 2 2019-02-15, 09:27

Version 1 2018-07-17, 09:50

dataset

posted on 2020-04-09, 13:59 authored by John Wilding, Kevin Fernando, Nicola Milne, Marc Evans, Amar Ali, Steve Bain, June James, Philip Newland-Jones, Dipesh Patel, Adie Viljoen

Article full text

The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.

The above features represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).